Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
K. E. Smedby, T. Wästerlid, E. Tham, Z. Haider, J. Joelsson, B. Thorvaldsdottir, A. Krstic, B. E. Wahlin, H. Foroughi-Asl, C. Karlsson, S. Eloranta, L. Saft, M. Palma, A. Kwiecinska, L. Hansson, A. Österborg, V. Wirta, G. Rassidakis, B. Sander, K. Sonnevi & R. Rosenquist. (2023) The BioLymph study – implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results. Acta Oncologica 62:6, pages 560-564.
Read now
Read now
Bengt Glimelius & Peter Nygren. (2019) Lessons learned from the maturation of a cancer drug: oxaliplatin in colorectal cancer. Acta Oncologica 58:4, pages 395-397.
Read now
Read now
L. M. Soveri, A. Lamminmäki, U. A. Hänninen, M. Karhunen, P. Bono & P. Osterlund. (2019) Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy. Acta Oncologica 58:4, pages 398-406.
Read now
Read now
Sofie Walming, Dan Asplund, Mattias Block, David Bock, Elisabeth Gonzalez, Carina Rosander, Jacob Rosenberg & Eva Angenete. (2018) Patients with rectal cancer are satisfied with in-hospital communication despite insufficient information regarding treatment alternatives and potential side-effects. Acta Oncologica 57:10, pages 1311-1317.
Read now
Read now
Bengt Glimelius, Jan Kowalski & Jacques Näsström. (2018) The PLIANT trial gives trustworthy data. Acta Oncologica 57:6, pages 864-866.
Read now
Read now
Bengt Glimelius, Nebojsa Manojlovic, Per Pfeiffer, Baadur Mosidze, Galina Kurteva, Mia Karlberg, Devalingam Mahalingam, Peter Buhl Jensen, Jan Kowalski, Marie Bengtson, Malin Nittve & Jacques Näsström. (2018) Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx®): a placebo-controlled randomised phase II study (PLIANT). Acta Oncologica 57:3, pages 393-402.
Read now
Read now
Camilla Böckelman & Bengt Glimelius. (2017) Need for adjuvant chemotherapy after colon cancer surgery – has it decreased?. Acta Oncologica 56:5, pages 629-633.
Read now
Read now
Bengt Glimelius. (2017) On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery. Upsala Journal of Medical Sciences 122:1, pages 1-10.
Read now
Read now
Articles from other publishers (21)
Vahid Zand, Mohammad Mandegari, Mohammadhossein Baradaranfar, Sedighe Vaziribozorg & Ali Shahzeidi. (2024) The effect of cisplatin-based chemotherapy on hearing loss (the frequency of >8 kHz) in children with cancer. American Journal of Otolaryngology 45:2, pages 104127.
Crossref
Crossref
I-Ya Wang, Sui-Whi Jane, Hung-Chih Hsu, Yung-Chang Lin, Wen-Sy Tsai, Chia-Yung Young, Randal D. Beaton & Hsiang-Ping Huang. (2023) The Longitudinal Trends of Care Needs, Psychological Distress, and Quality of Life and Related Predictors in Taiwanese Colorectal Cancer Survivors. Seminars in Oncology Nursing 39:4, pages 151424.
Crossref
Crossref
Robert B. Hines, Christopher Schoborg, Timothy Sumner, Xiang Zhu, Elizabeth A. Elgin & Shunpu Zhang. (2023) The association between sociodemographic, clinical, and potentially preventive therapies with oxaliplatin-induced peripheral neuropathy in colorectal cancer patients. Supportive Care in Cancer 31:7.
Crossref
Crossref
Wei Li, Lu Xiao, Zao-qin Yu, Min Li, Xi-min Wang, Dong Liu & Cheng-liang Zhang. (2022) Attention and Intervention of Oncologists on Oxaliplatin-induced Adverse Reactions in Mainland China: A Cross-sectional Internet-based Survey. Current Medical Science 42:6, pages 1319-1324.
Crossref
Crossref
Per Pfeiffer, Maryam Lustberg, Jacques Näsström, Stefan Carlsson, Anders Persson, Fumiko Nagahama, Guido Cavaletti, Bengt Glimelius & Kei Muro. (2022) Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M). JNCI Cancer Spectrum 6:6.
Crossref
Crossref
Kayikci Emel Emine & Can Gulbeyaz. (2022) The effect of salt-water bath in the management of treatment-related peripheral neuropathy in cancer patients receiving taxane and platinum-based treatment. EXPLORE 18:3, pages 347-356.
Crossref
Crossref
Leonard P. Rybak, Debashree Mukherjea & Vickram Ramkumar. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
732
754
.
Ya-Ning Chan, Ashley Leak Bryant, Jamie Conklin, Tyra Girdwood, Aaron Piepmeier & Rachel Hirschey. (2021) Systematic Review of Cognitive Impairment in Colorectal Cancer Survivors Who Received Chemotherapy. Oncology Nursing Forum 48:6, pages 634-647.
Crossref
Crossref
Barliz Waissengrin, Dan Mirelman, Sharon Pelles, Felix Bukstein, Deborah T. Blumenthal, Ido Wolf & Ravit Geva. (2021) Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis. Therapeutic Advances in Medical Oncology 13, pages 175883592199020.
Crossref
Crossref
Shu-Chen Chen, Hsiang-Ping Huang, Wen-Shih Huang, Yung-Chang Lin, Tsui-Ping Chu, Randal D. Beaton & Sui-Whi Jane. (2020) Non-randomized preliminary study of an education and elastic-band resistance exercise program on severity of neuropathy, physical function, muscle strength and endurance & quality of life in colorectal cancer patients experiencing oxaliplatin-induced peripheral neuropathy. European Journal of Oncology Nursing 49, pages 101834.
Crossref
Crossref
Takashi Sakamoto, Koya Hida, Nobuaki Hoshino, Takashi Yamaguchi, Dai Manaka, Masahiro Yamada, Yoshio Kadokawa, Satoshi Yamanokuchi, Masato Kondo, Akiyoshi Kanazawa, Hiroyasu Abe, Tomoaki Okada, Satoshi Morita & Yoshiharu Sakai. (2020) Changes in the sexual function of male patients with rectal cancer over a 2‐year period from diagnosis to 24‐month follow‐up: A prospective, multicenter, cohort study. Journal of Surgical Oncology 122:8, pages 1647-1654.
Crossref
Crossref
Benjamin K. Gersten, Tracy S. Fitzgerald, Katharine A. Fernandez & Lisa L. Cunningham. (2020) Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents. Journal of the Association for Research in Otolaryngology 21:4, pages 303-321.
Crossref
Crossref
Jenny Drott, Victoria Fomichov, Sussanne Börjeson & Carina Berterö. (2019) Sense of coherence and health‐related quality of life in patients with neurotoxicity after cancer chemotherapy: Assessment from a real‐time mobile phone–based system. Psycho-Oncology 29:1, pages 107-113.
Crossref
Crossref
Jianhong Peng, Weihao Li, Rongxin Zhang, Junzhong Lin, Jinghua Tang, Yongshan Wen, Zhenhai Lu, Xiaojun Wu & Zhizhong Pan. (2019) Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single‐center experience. Cancer Communications 39:1, pages 1-12.
Crossref
Crossref
Jenny Drott, Victoria Fomichov, Hans Starkhammar, Sussanne Börjeson, Karin Kjellgren & Carina Berterö. (2019) Oxaliplatin-Induced Neurotoxic Side Effects and Their Impact on Daily Activities. Cancer Nursing 42:6, pages E40-E48.
Crossref
Crossref
Gabriella Buccafusca, Ilaria Proserpio, Antonino Carmelo Tralongo, Sebastiano Rametta Giuliano & Paolo Tralongo. (2019) Early colorectal cancer: diagnosis, treatment and survivorship care. Critical Reviews in Oncology/Hematology 136, pages 20-30.
Crossref
Crossref
Shu‐Yi Hsu, Wen‐Shih Huang, Shu‐Hui Lee, Tsui‐Ping Chu, Yung‐Chang Lin, Chang‐Hsien Lu, Randal D. Beaton & Sui‐Whi Jane. (2018) Incidence, severity, longitudinal trends and predictors of acute and chronic oxaliplatin‐induced peripheral neuropathy in Taiwanese patients with colorectal cancer. European Journal of Cancer Care, pages e12976.
Crossref
Crossref
Nicolas Kerckhove, Aurore Collin, Sakhalé Condé, Carine Chaleteix, Denis Pezet, David Balayssac & Virginie Guastella. (2018) Neuropathies périphériques chimio-induites : symptomatologie et épidémiologie. Bulletin du Cancer 105:11, pages 1020-1032.
Crossref
Crossref
Jean-Baptiste Delmotte, Abdulkarim Tutakhail, Kahina Abdallah, Pauline Reach, Marguerite D’Ussel, Gael Deplanque, Hélène Beaussier & François Coudoré. (2018) Electrochemical Skin Conductance as a Marker of Painful Oxaliplatin-Induced Peripheral Neuropathy. Neurology Research International 2018, pages 1-9.
Crossref
Crossref
Lorenzo Di Cesare Mannelli, Mario Maresca, Laura Micheli, Carlo Farina, Michael W. Scherz & Carla Ghelardini. (2017) A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin. Cancer Chemotherapy and Pharmacology 80:6, pages 1091-1103.
Crossref
Crossref
Nicolas Kerckhove, Aurore Collin, Sakahlé Condé, Carine Chaleteix, Denis Pezet & David Balayssac. (2017) Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review. Frontiers in Pharmacology 8.
Crossref
Crossref